A case‐study of model‐informed drug development of a novel PCSK9 anti sense oligonucleotide. Part 1: First time in man to phase II

A case‐study of model‐informed drug development of a novel PCSK9 anti sense oligonucleotide. Part 1: First time in man to phase II

Abstract Here, we show model‐informed drug development (MIDD) of a novel antisense oligonucleotide, targeting PCSK9 for treatment of hypocholesteremia. The case study exemplifies use of MIDD to analyze emerging data from an ongoing first‐in‐human study, utility of the US Food and Drug Administration...

Full description

Saved in:
Bibliographic Details
Main Authors: Jane Knöchel (Author), Catarina Nilsson (Author), Björn Carlsson (Author), Linda Wernevik (Author), Alexis Hofherr (Author), Peter Gennemark (Author), Rasmus Jansson‐Löfmark (Author), Rikard Isaksson (Author), Tina Rydén‐Bergsten (Author), Bengt Hamrén (Author), Dinko Rekić (Author)
Format: Book
Published: Wiley, 2022-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items